Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

NCT00528684 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Oncolytics Biotech